drugset / Trial / NCT02284490

High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

NCT02284490 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well pemetrexed disodium works in treating patients with Lung Adenocarcinoma With Brain Metastases

Timeline

Start
2014-11
Primary completion
2016-10
Completion
2017-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 900 mg/m2 Intravenous